Concepedia

Ramona Schlenker

RS

14

Publications

1.2K

Citations

11

H-Index

2011

Active since

Affiliations

Roche (Switzerland)(Current)

Roche Pharma AG (Germany)

University Hospital of Zurich

ETH Zurich

University of Zurich

Ramona Schlenker is an author at Roche (Switzerland) specializing in immune regulation, tumor immunity, and t cell immunity.

Top concepts

Publications per year

2011–2024

14

Publications

14

Tumor-targeted 4-1BB agonists for combination with T cell bispecific antibodies as off-the-shelf therapy

Christina Claus, Claudia Ferrara, Wei Xu et al. · Science Translational Medicine · 2019 · 252 citations · Full text

PD-1-cis IL-2R agonism yields better effectors from stem-like CD8+ T cells

Laura Codarri Deak, Valeria Nicolini, Masao Hashimoto et al. · Nature · 2022 · 238 citations · Full text

CD20-TCB with Obinutuzumab Pretreatment as Next-Generation Treatment of Hematologic Malignancies

Marina Bacac, Sara Colombetti, Sylvia Herter et al. · Clinical Cancer Research · 2018 · 223 citations

A novel three-dimensional heterotypic spheroid model for the assessment of the activity of cancer immunotherapy agents

Sylvia Herter, Laura Morra, Ramona Schlenker et al. · Cancer Immunology Immunotherapy · 2016 · 136 citations · Full text

SCIM: universal single-cell matching with unpaired feature sets

Stefan G. Stark, Joanna Ficek, Francesco Locatello et al. · Bioinformatics · 2020 · 64 citations · Full text

Rows per page

1–5 of 14